92 results
Page 4 of 5
6-K
EX-99.3
odud20b
7 Dec 20
Updated data from the ALLCAR study suggests AUTO1’s potential for transformational activity in adult patients with r/r ALL
4:00pm
6-K
EX-99.2
xr6n8yg9yqj9smn1caie
5 Nov 20
Index to Condensed Consolidated Financial Statements
4:03pm
424B5
8xiuswxh674 n9i
18 Sep 20
Prospectus supplement for primary offering
8:01am
6-K
EX-99.1
lf069x4lkvmg
27 Aug 20
Autolus announces changes to its Board and Management Team
12:00am
6-K
EX-99.2
kb20mspchdb6wm6e
6 Aug 20
Current report (foreign)
4:06pm
6-K
EX-1
k288d 5qq
26 May 20
Current report (foreign)
4:31pm
6-K
EX-99.2
unmo8u 2e
7 May 20
Index to Condensed Consolidated Financial Statements
12:00am
424B5
kh0ctjy0mlg 45zpxo8
24 Jan 20
Prospectus supplement for primary offering
4:11pm
424B5
zw659ankbz0c58h1v
22 Jan 20
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.2
gysi ypjz8jdeujbsfb8
7 Nov 19
Index to Condensed Consolidated Financial Statements
4:28pm
6-K
EX-99.2
t2j4yxk0zse6 m6otn
8 Aug 19
Index to Condensed Consolidated Financial Statements
4:36pm
424B5
4x3d6plq217
24 Jul 19
Prospectus supplement for primary offering
4:20pm
F-3
nuf6 lxe58sufuqk043
17 Jul 19
Shelf registration (foreign)
5:15pm
6-K
EX-99.2
zk3r0zh
14 May 19
Index to Condensed Consolidated Financial Statements
4:32pm
424B4
9tchkz umv2rl4luo
11 Apr 19
Prospectus supplement with pricing info
4:10pm
F-1
97nbjyvl15forz06ju
8 Apr 19
Registration statement (foreign)
4:34pm
6-K
EX-99.2
xbb95pxxl9zhbi
2 Apr 19
Initial Results from Autolus Therapeutics’ ALLCAR19 Phase 1/2 Trial in Adult
7:52am
6-K
EX-1
etnwy9gim
15 Mar 19
Annual Report and Accounts
5:26pm
6-K
EX-2
eorfv93 3yxu6cfsu
15 Mar 19
Annual Report and Accounts
5:26pm